💊 Drugs • 12,141 recalls
Avella of Deer Valley, Inc. Store 38
Lack of Assurance of Sterility: Potential leakage of bags.
La Vita Compounding Pharmacy
Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.
La Vita Compounding Pharmacy
Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.
La Vita Compounding Pharmacy
Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.
Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.
Mylan Pharmaceuticals
Subpotent Drug
Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
Wockhardt Limited
Failed Impurities/Degradation Specifications
AMERICAN HEALTH PACKAGING
Failed Impurities/Degradation Specification; out-of-specification results for the Enalapril DKT degradant
Wockhardt Limited
Failed Impurities/Degradation Specifications
Presence of Particulate Matter: identified as glass and silicone material
CGMP Deviations
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Subpotent Drug and Failed Content Uniformity.
Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.
Medi-Fare Drug and Home Health Center
CGMP Deviations: Syringes were filled with 19mL of potassium chloride when the labels displayed a fill of 20mL.
Fagron Compounding Services LLC
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Labeling: Incorrect or Missing Lot and/or Exp Date.
Superpotent Drug: High out of specification assay value results for potency.
Fagron Compounding Services LLC
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.